ResearchMoz

Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media

GBI Research
Published Date » 2012-07-10
No. Of Pages » 62
   
 GBI Research, the leading business intelligence provider, has released its latest research, Direct to Consumer (DTC) Advertising in Pharmaceuticals Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media, which provides insights into the up-and-coming trends of DTC advertising in the US and of awareness campaigns in Europe. The report provides an in-depth analysis of the types of marketing channels available to pharmaceutical marketers. In particular it focuses on how pharmaceutical marketers can make the most of digital media channels, including online advertising and social media. 
   
 The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs...
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7

2 Direct to Consumer (DTC) Advertising in Pharmaceuticals -Introduction 8

3 Direct to Consumer (DTC) Advertising in Pharmaceuticals Media Types 11

3.1 Traditional Media Types 13
3.1.1 Television 13
3.1.2 Print 17
3.1.3 Other 18
3.2 Online and Social Media 18
3.2.2 Advertisement Placement 20
3.2.3 Twitter 21
3.2.4 Facebook 27
3.2.5 YouTube 27
3.3 Mobile 28
3.3.1 The Importance of a Mobile-enabled Website 28
3.3.2 Applications 28
3.4 Managing Media Types 29
3.4.1 Increasing and Measuring ROI of Social Media 29
3.4.2 Choosing the Correct Media Mix 36

4 DTC Advertising in the US 39
4.1 Introduction 39
4.1.1 History of DTC in the US 39
4.1.2 Impact of DTC in the US 41
4.1.3 Current DTC US Market 42
4.2 FDA Regulations 44
4.2.1 2011 Guidance for Industry the FDAs Response to Social Media Use 44
4.2.2 45-Day Ad Review 45
4.3 Innovative Campaign Examples 46
4.3.1 Lantus (Insulin Glargine) Sanofi US 46
4.3.2 Spiriva Boehringer Ingelheim Pharmaceuticals Inc. 46
4.4 Controversial Campaign Examples 47
4.4.1 Copaxone (Glatiramer Acetate) Teva Pharmaceutical Industries 47
4.4.2 Victoza (Liraglutide [rDNA Origin] Injection) Novo Nordisk A/S 49

5 European Union 51
5.1 Introduction 51
5.2 EU Regulations for DTC Advertising 51
5.2.1 High Level Pharmaceutical Forum A Move to Push Branded DTC Advertising in Europe 52
5.2.2 EC Proposal on Restricted Branded Advertising Possible Entry Point for DTC Advertising Penetration in the Continent 52
5.2.3 Budget Cuts and National Health Services 53
5.2.4 Awareness Campaigns 53
5.3 Conclusion 54

6 Other Markets 55
6.1 New Zealand 55
6.2 Trans-Tasman Initiative 55

7 Conclusion 56

8 Key Takeaway 57

9 Appendix 58

9.1 Market Definitions 58
9.2 Social Media Definitions 58
9.3 Abbreviations 59
9.4 Sources 59
9.5 Research Methodology 60
9.5.1 Coverage 60
9.5.2 Secondary Research 61
9.5.3 Primary Research 61
9.5.4 Competitive Landscape 61
9.5.5 Expert Panel Validation 62
9.6 Contact Us 62
9.7 Disclaimer 62

List of Tables


Table 1: Direct to Consumer Advertising in Pharmaceuticals, Media Type Comparisons 12
Table 2: Differences in the US and Europe Healthcare System in the Context of DTC Advertising 51

List of Figures


Figure 1: Direct to Consumer Advertising in Pharmaceuticals, DTC Spend by Therapeutic Class,%, 2011 9
Figure 2: Direct to Consumer Advertising in Pharmaceuticals, Total Promotional Spending on Prescription Drugs, $bn, 19962011 10
Figure 3: Direct to Consumer Advertising in Pharmaceuticals , DTC Average Budget Allocation, DTC Expenditure on Top Three Media Types, %, 2010 11
Figure 4: Direct to Consumer Advertising in Pharmaceuticals, FDA Guidelines on DTC Marketing of Pharmaceuticals, 2009 14
Figure 5: Direct to Consumer Advertising in Pharmaceuticals, Factors Influencing Decrease in DTC Spending, 20072011 16
Figure 6: Direct to Consumer Advertising in Pharmaceuticals, Proliferation of Brand Message Through Word of Mouth 19
Figure 7: Direct to Consumer Advertising in Pharmaceuticals, Top 10 Most Visited Social Network Sites in the US, 2011 20
Figure 8: Direct to Consumer Advertising in Pharmaceuticals, Twitter Account Information 15 Major Pharmaceutical Users 22
Figure 9: Direct to Consumer Advertising in Pharmaceuticals, Most Commonly Tweeted Topic for Pharmaceutical Accounts 23
Figure 10: Direct to Consumer Advertising in Pharmaceuticals, Tweet Topics AstraZenecas Tweet Chat, 2011 24
Figure 11: Direct to Consumer Advertising in Pharmaceuticals, AstraZeneca, Consumer Sentiment During Twitter Chat, 2011 25
Figure 12: Direct to Consumer Advertising in Pharmaceuticals, Tweet Topics Shires @ADHDSupport 26
Figure 13: Direct to Consumer Advertising in Pharmaceuticals, Types of YouTube Advertisement 28
Figure 14: Direct to Consumer Advertising in Pharmaceuticals, Campaign Reach 31
Figure 15: Direct to Consumer Advertising in Pharmaceuticals, Campaign Engagement 32
Figure 16: Direct to Consumer Advertising in Pharmaceuticals, Campaign Attention 33
Figure 17: Direct to Consumer Advertising in Pharmaceuticals, Campaign Positive Sentiment, % 33
Figure 18: Direct to Consumer Advertising in Pharmaceuticals, Social Media Promotion to Prescription 34
Figure 19: Direct to Consumer Advertising in Pharmaceuticals, Factors for Budget Allocation and Media Mix 36
Figure 20: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change of National Health Expenditure, 19702010 41
Figure 21: Direct to Consumer Advertising in Pharmaceuticals, US DTC Spend by Company, $m, 2011 42
Figure 22: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change in US DTC Spend by Company, 2010 2011 42
Figure 23: Direct to Consumer Advertising in Pharmaceuticals, US DTC Spend by Brand, $m, 2011 43
Figure 24: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change in US DTC Spend by Brand, 20102011 43
Figure 25: Direct to Consumer Advertising in Pharmaceuticals, Team Copaxone Campaign Regulation Breaching Statements 48
Figure 26: Royal Pharmaceutical Society of Great Britain on EU Proposal to Allow Restricted Branded DTC Advertising 53

Upcoming Reports:

Gluten Free Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
The reason for the inception of gluten free products is the fact that gluten rich food is known to cause a disease known as celiac disease. It’s a condition wherein the patient’s immune system gets auto-triggered when they consume foods containing gluten. There is no medication available currently to cure this disease and the only way possible to avoid it is to switch to a gluten free diet. The gluten free products are experiencing a substantial growth due to various health benefits associated with it. The conviction that gluten free products are healthier than...
Anti-Adhesion Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Adhesion is one of the common problems affecting almost 55% to 90% patients followed by surgery. Adhesion is a band of scar tissue formed between organs and tissue after a surgery as a part of a normal healing process. However, when it connects wrong tissues into each other, adhesions may lead to severe clinical symptoms such as pelvic pain, intestinal blockage, infertility and loss of sensation depending on the location and size of the adhesions.  Adhesions are most common after surgeries such as abdominal surgery, thoracic surgery, gynaecological surgery and plastic surgery....
Poland: soap market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the soap market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the soap market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...